Who owns Alexion Pharmaceuticals?

Key details on Alexion Pharmaceuticals (Ticker: ALXN)

Who owns Alexion Pharmaceuticals?

Is ALXN a good stock to own? Find out who bought Alexion Pharmaceuticals, who sold Alexion Pharmaceuticals (ALXN) stock, and who holds a large position in Alexion Pharmaceuticals.

Fund Name Number of Shares Share Valuation As Of
OTR - Nominee Name for The State Teachers Retirement Board of Ohio 100.55M $100.55M March 31, 2015
Capital Research Global Investors^ 24.76M $4.29B March 31, 2015
T. Rowe Price Associates 22.08M $3.83B March 31, 2015
FMR 19.68M $3.41B March 31, 2015
Vanguard 11.27M $1.95B March 31, 2015
STATE STREET CORPORATION 8.47M $1.47B March 31, 2015
VIKING GLOBAL INVESTORS 5.54M $511.47M June 30, 2013
JPMORGAN CHASE & CO 5.54M $959.55M March 31, 2015
BlackRock Institutional Trust Company, N.A. 5.30M $917.77M March 31, 2015
Jennison Associates 5.24M $908.13M March 31, 2015
Sands Capital Management 5.20M $901.90M March 31, 2015
Wells Fargo & Company 4.28M $742.47M March 31, 2015
Inves 4.15M $631.87M March 31, 2014
BlackRock Fund Advisors 4.09M $709.07M March 31, 2015
Columbia Wanger Asset Management 3.71M $344.78M March 31, 2012
American Century Companies 3.67M $262.46M Dec. 31, 2011

Who sold Alexion Pharmaceuticals?

Fund Name Date Sold Number of Shares Sold Share Valuation
Ameriprise Financial June 30, 2011 6.24M $293.38M